Combined dapsone and sulfapyridine for the treatment of therapy-resistant linear IgA bullous dermatosis: Two case reports

Detalles Bibliográficos
Autores principales: Herlin, Laura Krogh, Deleuran, Mette, Pallesen, Kristine, Bregnhøj, Anne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8856946/
https://www.ncbi.nlm.nih.gov/pubmed/35242961
http://dx.doi.org/10.1016/j.jdcr.2021.12.030
_version_ 1784653950755012608
author Herlin, Laura Krogh
Deleuran, Mette
Pallesen, Kristine
Bregnhøj, Anne
author_facet Herlin, Laura Krogh
Deleuran, Mette
Pallesen, Kristine
Bregnhøj, Anne
author_sort Herlin, Laura Krogh
collection PubMed
description
format Online
Article
Text
id pubmed-8856946
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-88569462022-03-02 Combined dapsone and sulfapyridine for the treatment of therapy-resistant linear IgA bullous dermatosis: Two case reports Herlin, Laura Krogh Deleuran, Mette Pallesen, Kristine Bregnhøj, Anne JAAD Case Rep Case Report Elsevier 2022-01-19 /pmc/articles/PMC8856946/ /pubmed/35242961 http://dx.doi.org/10.1016/j.jdcr.2021.12.030 Text en © 2022 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Herlin, Laura Krogh
Deleuran, Mette
Pallesen, Kristine
Bregnhøj, Anne
Combined dapsone and sulfapyridine for the treatment of therapy-resistant linear IgA bullous dermatosis: Two case reports
title Combined dapsone and sulfapyridine for the treatment of therapy-resistant linear IgA bullous dermatosis: Two case reports
title_full Combined dapsone and sulfapyridine for the treatment of therapy-resistant linear IgA bullous dermatosis: Two case reports
title_fullStr Combined dapsone and sulfapyridine for the treatment of therapy-resistant linear IgA bullous dermatosis: Two case reports
title_full_unstemmed Combined dapsone and sulfapyridine for the treatment of therapy-resistant linear IgA bullous dermatosis: Two case reports
title_short Combined dapsone and sulfapyridine for the treatment of therapy-resistant linear IgA bullous dermatosis: Two case reports
title_sort combined dapsone and sulfapyridine for the treatment of therapy-resistant linear iga bullous dermatosis: two case reports
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8856946/
https://www.ncbi.nlm.nih.gov/pubmed/35242961
http://dx.doi.org/10.1016/j.jdcr.2021.12.030
work_keys_str_mv AT herlinlaurakrogh combineddapsoneandsulfapyridineforthetreatmentoftherapyresistantlinearigabullousdermatosistwocasereports
AT deleuranmette combineddapsoneandsulfapyridineforthetreatmentoftherapyresistantlinearigabullousdermatosistwocasereports
AT pallesenkristine combineddapsoneandsulfapyridineforthetreatmentoftherapyresistantlinearigabullousdermatosistwocasereports
AT bregnhøjanne combineddapsoneandsulfapyridineforthetreatmentoftherapyresistantlinearigabullousdermatosistwocasereports

Ejemplares similares